Renub Research Global Molecular Diagnostics Market & Future Forecast

Transcription

1 Renub Research Global Molecular Diagnostics Market & Future Forecast Publisher: Renub Research Published: July, 2011

2 Global Molecular Diagnostics - Market Overview The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The various application and technological sub-segments of molecular diagnostics are also giving the market a big push. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry. Molecular diagnostics is a vital and dynamic field in which yesterday s new technologies and platforms are today becoming populated with novel, diverse, and useful content. Growing with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 15 Billion by 2014.The fastest growing segment is infectious disease with 21% market share as the dominant segment. The next fastest growing segment is oncology testing due to rising cases of cancer patients.the future growth is expected to come from genetic testing, blood screening testing and neurological testing. Geographically, the US and EMEA markets are the most advanced in terms of adoption of molecular testing and make up the majority of the existing market. However, Japanese molecular diagnostics market is promising with the ageing population and a declining birth rate is putting the whole Japanese healthcare system under pressure. Under such circumstances, the role of preventive medical care is increasingly important. China and India molecular diagnostics market is one of the lucrative markets to rollout the diagnosis business. As with the rapid advancement Chinese and Indian economy has dramatically increased the purchasing power of a growing segment of the populace, which coupled with an emerging mindset toward wellness, preventive medicine, and access to cutting-edge products and services and makes the future outlook extremely positive for this very exciting new field in clinical care. The provision of new and cutting-edge molecular tests will surely be followed by greater affordability as prices come down due to return on investment, competition, and technology advancement. Renub Research Page 2 of 27

3 Report Details Global Molecular Diagnostics Market & Future Forecast report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering: Global Molecular Diagnostics Market (2008 to 2014) Top 8 application wise molecular diagnostics (Infectious Disease Testing, Blood Screening Testing, Oncology Testing, Genetic Testing, Tissue Typing Testing, Cardiovascular Disease Testing, Neurological Testing and Food Pathogen Detection Testing) data of Past, Present and Future Market (2008 to 2014) Top 7 technological wise molecular diagnostics (PCR based tests, PCR related technologies, Non-PCR tests, FISH & Innovation testing, Biochips, Biosensor & Other technologies) data of Past, Present and Future Market (2008 to 2014) Top 9 Countries (USA, Europe the Middle East & Africa, Japan, China, India, Germany, Brazil, Mexico and South Korea) data of Past, Present and Future Market Mergers and Acquisitions in the molecular diagnostics market Key drivers of growth in the molecular diagnostics market Key Players in the molecular diagnostics market Research Highlights Globally, Molecular Diagnostics market is expected to reach US$ 15 Billion by 2014 Infectious disease testing dominates the molecular diagnostics market with more than 21% market share in 2010 Oncology and infectious disease testing sectors are likely growth leaders in the molecular diagnostics market Blood Screening & Genetic testing will have a combined market share of 26% by 2014 Biochips market is expected to cross US$ 3 Billion by 2014 Fish & Innovation testing is expected to capture more than 16% market share by 2014 USA is expected to have more than US$ 6 Billion molecular diagnostics market by 2014 Renub Research Page 3 of 27

4 Key Players Analyzed This section covers the key facts about the major players in molecular diagnostics market. The key players analyzed in this section are Roche, Abbott, Bayer AG, Qiagen, Gen-Probe, Becton Dickinson and Company, biomérieux, Myriad Genetics, Inc., Celera Corporation. Data Sources Information and data in this report has been collected from various printable and nonprintable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations. Renub Research Page 4 of 27

5 About Us Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today s ultra-competitive markets. For more information on us or to view any of our sample work you can mail us at info@renub.com Renub Research Page 5 of 27

6 Published By Renub Research A 116B, Sector 27 Noida Phone: , (India) (USA) Fax : info@renub.com Global Molecular Diagnostics Market & Future Forecast Renub Research, 2011 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers Renub Research Page 6 of 27

7 Table of Contents 1. Executive Summary 2. Global Molecular Diagnostics Market & Market Shares (Application wise and Technological wise) 2.1 Molecular Diagnostics Market & Future Forecast 2.2 Molecular Diagnostics Market Share & Future Forecast (Application Segment) 2.3 Molecular Diagnostics Market Share & Future Forecast (Technologies Segment) 3. Molecular Diagnostics Market (Application Segment) 2008 to Infectious Disease Testing Market Virology Testing Market Haemagglutination-Inhibition Test (HAI) Testing Critical Care Infectious Testing Market 3.2 Blood Screening Market 3.3 Genetic Testing Market 3.4 Oncology Testing Market 3.5 Tissue Typing (HLA Testing) Market 3.6 Cardiovascular Disease Testing Market 3.7 Neurological Disorders Testing Market 3.8 Food Pathogen Detection Testing Market 4. Molecular Diagnostics Market (Technologies Segment) 2008 to PCR Based Test Market 4.2 PCR Related Technologies Market 4.3 Non-PCR Test Market 4.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization) 4.5 Biochips Market 4.6 Biosensors 4.7 Other Technologies Market 5. Geographical Distribution - Molecular Diagnostics Market (2008 to 2014) Renub Research Page 7 of 27

8 5.1 United States Molecular Diagnostics Market 5.2 Europe, the Middle East & Africa (EMEA) Molecular Diagnostics Market 5.3 Germany Molecular Diagnostics Market 5.4 India Molecular Diagnostics Market 5.5 China Molecular Diagnostics Market 5.6 Japan Molecular Diagnostics Market 5.7 Brazil Molecular Diagnostics Market 5.8 Mexico Molecular Diagnostics Market 5.9 South Korea Molecular Diagnostics Market 6. Global Mergers & Acquisitions Deals in the Molecular Diagnostics Sector 7. Key Drivers of Growth in Global Molecular Diagnostics Market 7.1 Aging of the population 7.2 Re-Emergence of infectious threats (drug resistant TB, new strains of HIV, H1N1 & other flu) 7.3 Scientific and Technological Advancements 8. Challenges 8.1 Reimbursement 8.2 The need for new Biomarker Assays 8.3 Regulatory Environment 8.4 Awareness and Acceptance 9. Key Players 9.1 Roche 9.2 Abbott Laboratories 9.3 Qiagen 9.4 BD (Becton, Dickinson and Company) 9.5 biomerieux 9.6 Bayer AG 9.7 Gen-Probe 9.8 Myriad Genetics, Inc Renub Research Page 8 of 27

9 9.9 Celera Corporation 9.10 Beckman Coulter Renub Research Page 9 of 27

10 List of Figures: Figure 2-1: Global - Molecular Diagnostics Market (Million US$), Figure 2-2: Global - Forecast for Molecular Diagnostics Market (Million US$), Figure 2-3: Global - Segments of Molecular Diagnostics Market Share (Percent), Figure 2-4: Global - Forecast for Segments of Molecular Diagnostics Market Share (Percent), Figure 2-5: Global - Molecular Diagnostics Market Share Technologies wise (Percent), Figure 2-6: Global - Forecast for Molecular Diagnostics Market Share Technologies wise (Percent), Figure 3-1: Global - Infectious Disease Testing Market (Million US$), Figure 3-2: Global - Forecast for Infectious Disease Testing Market (Million US$), Figure 3-3: Global - Virology Testing Market (Million US$), Figure 3-4: Global - Forecast for Virology Testing Market (Million US$), Figure 3-5: Global - HAI Testing Market (Million US$), Figure 3-6: Global - Forecast for HAI Testing Market (Million US$), Figure 3-7: Global - Critical Care Infectious Testing Market (Million US$), Figure 3-8: Global - Forecast for Critical Care Infectious Testing Market (Million US$), Figure 3-9: Global - Blood Screening Market (Million US$), Figure 3-10: Global - Forecast for Blood Screening Market (Million US$), Figure 3-11: Global - Genetic Testing Market (Million US$), Figure 3-12: Global - Forecast for Genetic Testing Market (Million US$), Figure 3-13: Global - Oncology Market (Million US$), Figure 3-14: Global - Forecast for Oncology Market (Million US$), Figure 3-15: Global - Tissue Typing Market (Million US$), Figure 3-16: Global - Forecast for Tissue Typing Market (Million US$), Figure 3-17: Global - Cardiovascular Disease Testing Market (Million US$), Figure 3-18: Global - Forecast for Cardiovascular Disease Testing Market (Million US$), Figure 3-19: Global - Neurological Disorders Testing Market (Million US$), Figure 3-20: Global - Forecast for Neurological Disorders Testing Market (Million US$), Figure 3-21: Global - Food Pathogen Detection Testing Market (Million US$), Figure 3-22: Global - Forecast for Food Pathogen Detection Testing Market (Million US$), Figure 4-1: Global - PCR Based Test Market (Million US$), Figure 4-2: Global - Forecast for PCR Based Test Market (Million US$), Figure 4-3: Global - PCR Related Technologies Market (Million US$), Figure 4-4: Global - Forecast for PCR Related Technologies Market (Million US$), Figure 4-5: Global - Non-PCR Test Market (Million US$), Figure 4-6: Global - Non-PCR Test Market (Million US$), Renub Research Page 10 of 27

11 Figure 4-7: Global - Fish & Innovations Market (Million US$), Figure 4-8: Global - Forecast for Fish & Innovations Market (Million US$), Figure 4-9: Global - Biochips/ Microarrays Market (Million US$), Figure 4-10: Global - Forecast for Biochips/Micrroarrays Market (Million US$), Figure 4-11: Global - Biosensors Market (Million US$), Figure 4-12: Global - Forecast for Biosensors Market (Million US$), Figure 4-13: Global - Other Technologies Market (Million US$), Figure 4-14: Global - Forecast for Other Technologies Market (Million US$), Figure 5-1: US - Molecular Diagnostics Market (Million US$), Figure 5-2: US - Forecast for Molecular Diagnostics Market (Million US$), Figure 5-3: EMEA - Molecular Diagnostics Market (Million US$), Figure 5-4: EMEA - Forecast for Molecular Diagnostics Market (Million US$), Figure 5-5: Germany - Molecular Diagnostics Market (Million US$), Figure 5-6: Germany - Forecast for Molecular Diagnostics Market (Million US$), Figure 5-7: India - Molecular Diagnostics Market (Million INR), Figure 5-8: India - Forecast for Molecular Diagnostics Market (Million INR), Figure 5-9: China - Molecular Diagnostics Market (Million US$), 2004, Figure 5-10: China - Forecast for Molecular Diagnostics Market (Million US$), Figure 5-11: Japan - Molecular Diagnostics Market (Million US$), Figure 5-12: Japan - Forecast for Molecular Diagnostics Market (Million US$), Figure 5-13: Brazil - Molecular Diagnostics Market (Million US$), Figure 5-14: Brazil - Forecast for Molecular Diagnostics Market (Million US$), Figure 5-15: Mexico - Molecular Diagnostics Market (Million US$), Figure 5-16: Mexico - Forecast for Molecular Diagnostics Market (Million US$), Figure 5-17: South Korea - Molecular Diagnostics Market (Million US$), Figure 5-18: South Korea - Forecast for Molecular Diagnostics Market (Million US$), Figure 7-1: Global - Population Aged 60 or Over: World and Development Regions, 1950, 1975, 2009, 2025 & 2050 Figure 7-2: Old-age Dependency Ratio: Major Areas, 2009 & 2050 Renub Research Page 11 of 27

12 List of Tables: Table 6-1: Global - Mergers & Acquisitions Deals in the Molecular Diagnostics Sector (Million US$) Table 7-1: Global - Population Aged 60 or Over, 65 or Over and 80 Or Over By Sex (Thousands): World, Major Areas and Regions, 2009 Table 9-1: Roche - Key Financials (Million US$) Table 9-2: Abbott Laboratories - Key Financials (Million US$) Table 9-3: Qiagen - Key Financials (Million US$) Table 9-4: BD (Becton, Dickinson and Company) - Key Financials (Million US$) Table 9-5: Biomerieux - Key Financials (Million US$) Table 9-6: Bayer AG - Key Financials (Million US$) Table 9-7: Gen Probe - Key Financials (Million US$) Table 9-8: Myriad Genetics, Inc. Key Financials (Million US$) Table 9-9: Celera Corporation - Key Financials (Million US$), Table 9-10: Beckman Coulter - Key Financials (Million US$) Renub Research Page 12 of 27

13 2. Global Molecular Diagnostics Market & Market Shares (Application wise and Technological wise) 2.1 Molecular Diagnostics Market & Future Forecast Molecular Diagnostics market is one of the fastest growing markets in the diagnostics segment. In 2010 molecular diagnostics market was whopping US$ 7,287 Million and it is projected to be US$ 14,864 Million by The market is expected to grow with 19.5 percent CAGR for the period of 2010 to Molecular diagnostics will continue to grow in importance for both the IVD community and personalized medicine, but there have been significant structural changes in the category in the coming years. Trends and Directions to Expect In Molecular Diagnostics Sector shakeout will continue as access to capital remains tight and investment needs tighten due to an increased need to develop routes to market Established diagnostics and healthcare companies will acquire and tie-up assets of promising pure play companies, especially in the areas of infectious disease and oncology There will be an increased focus on novel, portable molecular diagnostics platforms to enable the next phase of growth, ease of use and clinical value Pharma and biotech companies will look to take advantage of the downturn in valuation and the potential tax-credits proposed in The Genomics and Personalized Medicine Act of 2008 Revenue growth will continue to favor MDx companies that also have the ability to deliver test results as a service due to the limited options for in house capabilities or reference labs. Renub Research Page 13 of 27

14 Figure 2-2: Global - Forecast for Molecular Diagnostics Market (Million US$), ,000 14,864 Million US$ 14,000 12,000 10,000 8,000 6,000 8,550 10,161 12,225 4,000 2, Source: Scientia Analysis, Kalorama, Frost & Sullivan, Company reports and presentations,tsg analysis, Qiagen, Roche, Hologic presentations, Renub Research Analysis 2.2 Molecular Diagnostics Market Share & Future Forecast (Application Segment) The molecular diagnostics industry is characterized by a very diverse, constantly changing technology base that continuously produces new opportunities and applications. Similarly, a growing understanding of the molecular basis of cancer and other chronic diseases is opening up new realms of medicine to the possibilities of molecular diagnostics testing. Infectious disease testing with 21.8% accounts for largest share in global molecular diagnostics market in Oncology testing should post strong position in the molecular diagnostics industry due to rising cases of cancer patients that leads the market share with 22.95% by 2011 and it is further expected to grow to 28.59% market share by The future growth in the molecular diagnostics industry is also expected to come from genetic testing, blood screening testing and neurological testing. Renub Research Page 14 of 27

15 Figure 0-1: Global - Segments of Molecular Diagnostics Market Share (Percent), Percent 100% 90% 80% 70% 60% 50% 40% Food Pathogen Detection Testing Neurological Testing Cardiovascular Disease Testing Tissue Typing Testing Oncology Testing 30% 20% 10% Genetic Testing Blood Screening Testing 0% Infectious Disease Testing Source: Diagnosing Diagnostics Thomas Weisel Partners, 19 March 2007, Devices and predictive diagnostics, Burill & Co.,7 May 2007, Gen Probe 28th Annual JP Morgan Healthcare Conference, 2009 estimates by Piper Jaffray (April 2010) and Gen-Probe, Scientia Analysis, Kalorama, Frost & Sullivan, Company reports and presentations, TSG analysis, Qiagen, Roche, Hologic presentations, Luminex Corporation J.P. Morgan Healthcare Conference, Gen Probe 28th Annual JP Morgan Healthcare Conference, Jain PharmaBiotech, Renub Research Analysis 2.3 Molecular Diagnostics Market Share & Future Forecast (Technologies Segment) Biochips and PCR based test accounts for the largest shares in the molecular diagnostics technologies segment with 24.21% and 18.42% respectively in With the advancement of technology, biochips has became a major thrust for the rapidly growing diagnostics industry, which encompasses a very diverse range of research efforts including genomics, proteomics, and other activities. The driving growth factor of PCR Based test is now a common and often indispensable technique used in medical and biological research labs for a variety of applications. These include DNA cloning for sequencing, DNA-based phylogeny, or functional analysis of genes; the diagnosis of hereditary diseases; the identification of genetic fingerprints (used in forensic sciences and paternity testing); and the detection and diagnosis of infectious diseases. Renub Research Page 15 of 27

16 Fish Testing Market is the fastest growing segment and projected to grow with 16.79% CAGR, from 2010 to The market for FISH-based molecular diagnostic tools has been attractive and will remain so in the foreseeable future. The vast majority of molecular diagnostic tests rely on detection of nucleic acids and use of fluorescence, for sequencing and real-time polymerase chain reaction (PCR), chemiluminescence for transcription-mediated amplification, or a chromogenic method such as in situ hybridization. Fish & Innovation testing is expected to capture 16.87% market share by Figure 0-2: Global - Molecular Diagnostics Market Share Technologies wise (Percent), % 90% Other Technologies Percent 80% 70% 60% 50% 40% 30% Biosensor Fish and Innovation Non-PCR Tests PCR Related Technologies 20% 10% 0% PCR Based Test Biochips/Microarrays Source: Jain PharmaBiotech, Renub Research Analysis Renub Research Page 16 of 27

17 3 Molecular Diagnostics Market (Application Segment) 2008 to Infectious Disease Testing Market An infectious disease is a clinically evident disease resulting from the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multi cellular parasites, and aberrant proteins known as prions. The infectious disease testing market is one of the most rapidly growing segments of the molecular diagnostics industry. The continuous identification of new gene targets has enhanced the spectrum of disease profiles for the molecular diagnostic market. However, the increasing incidences of human immunodeficiency virus (HIV), hepatitis C (HCV), hepatitis B virus (HBV), chlamydia and gonorrhea have escalated the infectious disease diagnostics segment to be a major contributor to the revenue growth of the molecular diagnostics market. Although, some infections are still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products. With a high incidence of infectious diseases in developing countries, the need for appropriate and early diagnosis of these diseases is assuming greater importance. The high disease burden combined with increasing focus from both, regional governments and global communities to treat these diseases makes developing countries an attractive market for manufacturers of diagnostics for infectious diseases. Increased international funding and government initiatives that are expected to promote growth in the infectious disease diagnostics market. But the major challenge in the markets is to develop diagnostic tests at affordable prices. The plethora of diseases offers the researchers to develop novel biomarkers both for disease identification and treatment. However, commercialization of these tests is a challenge, as manufacturers will need to strike a balance between development costs and profit margins. Renub Research Page 17 of 27

18 Currently, the largest market application segment for molecular diagnostics is infectious disease testing. The segment is expected to grow at an annual rate of % between 2008 and 2014.Over the next few years it will present some excellent market opportunities for molecular diagnostic competitors in the infectious disease market. The market was bullish since 2008 with the sales of US$ 1,207 Million, the market further rose to US$ 1,592 Million in 2010 and it is predicted that the market will be clinching for the sales of US$ 3,778 Million by Figure 3-1: Global - Forecast for Infectious Disease Testing Market (Million US$), ,000 3,778 3,500 3,000 2,917 Million US$ 2,500 2,000 1,500 1,895 2,318 1, Source: Scientia Analysis, Kalorama, Frost & Sullivan, Company reports and presentations, Renub Research Analysis Renub Research Page 18 of 27

19 3.4 Oncology Testing Market In addition to the infectious disease area, molecular diagnostics technology is now being applied in a wide range of applications. Another major market segment consists of molecular oncology tests. A significant challenge for diagnostics companies in developing molecular diagnostics tests for cancer has been the identification and validation of biomarkers for cancer, but progress is being made and tests are reaching the market. Oncology tests can be used for many different indications, including identifying patients at risk of developing cancer, screening for early detection of cancer, determining prognosis, predicting response to therapy, and monitoring patients during and after treatment. The oncology testing market were US$ 1,516 Million in 2010 and it is expected to reach US$ 4,249 Million by 2014 with the annual growth rate of 29.39% between 2007 and Figure 3-2: Global - Forecast for Oncology Market (Million US$), Million US$ 4,500 4,000 3,500 3,000 2,500 2,000 1,500 1, ,249 3,285 2,539 1, Source: TSG analysis, Qiagen, Roche, Hologic presentations, Renub Research Analysis Renub Research Page 19 of 27

20 4 Molecular Diagnostics Market (Technologies Segment) 2008 to Fish & Innovations Testing Market (Fluorescent in-situ hybridization) A method of staining biological tissue samples to identify the presence and copy number of specific genes or genetic mutations in cells; used in the diagnosis of cancer and other diseases. The market for FISH-based molecular diagnostic tools has been attractive and will remain so in the foreseeable future. The vast majority of molecular diagnostic tests rely on detection of nucleic acids and use of fluorescence, for sequencing and real-time polymerase chain reaction (PCR), chemiluminescence for transcription-mediated amplification, or a chromogenic method such as in situ hybridization. The FISH testing market rose to US$ 1,400 Million in 2010 and it is predicted that market will reach to US$ 2,605 Million by Figure 4-7: Global - Fish & Innovations Market (Million US$), Million US$ 1,600 1,400 1,200 1, ,009 1,100 1,200 1, Source: Jain PharmaBiotech, Renub Research Analysis Renub Research Page 20 of 27

21 4.5 Biochips Market The development of biochips is a major thrust for the rapidly growing biotechnology industry, which encompasses a very diverse range of research efforts including genomics, proteomics, and pharmaceuticals, among other activities. Advances in these areas are giving scientists new methods for unraveling the complex biochemical processes occurring inside cells, with the larger goal of understanding and treating human diseases. At the same time, the semiconductor industry has been steadily perfecting the science of micro-miniaturization. The merging of these two fields in recent years has enabled biotechnologists to begin packing their traditionally bulky sensing tools into smaller and smaller spaces, onto so-called biochips. These chips are essentially miniaturized laboratories that can perform hundreds or thousands of simultaneous biochemical reactions. Biochips enable researchers to quickly screen large numbers of biological analytic for a variety of purposes, from disease diagnosis to detection of bioterrorism agents. The biochips market is booming with the advancement of the technology. The biochips market rose to US$ 2,300 Million in 2010 and it is expected that market will grow to US$ 3,742 Million by Figure 4-1: Global - Forecast for Biochips/Micrroarrays Market (Million US$), Million US$ 4,000 3,500 3,000 2,500 2,000 1,500 2,450 3,000 3,450 3,742 1, Source: Jain PharmaBiotech, Renub Research Analysis Renub Research Page 21 of 27

22 5 Geographical Distribution - Molecular Diagnostics Market (2008 to 2014) 5.1 United States Molecular Diagnostics Market Molecular diagnostics segment is boon for the players who are doing the research as well as manufacturing the product in United States. In recent years molecular diagnostics sector has shown the phenomenal growth in the diagnostics segment. Due to rising demand for diagnostics tests as population of baby boomers is aging in United States. The molecular diagnostics market pegged to US$ 3,175 Million in 2010 and it is predicted that the market will grow to US$ 6,138 Million by The infectious disease testing and blood-banking applications will lead the way. Oncology diagnostics should post strong numbers in the years to come due to rising cases of cancer patients in United States. Figure 5-1: US - Molecular Diagnostics Market (Million US$), ,500 3,000 2,778 3,175 Million US$ 2,500 2,000 1,500 1, ,032 1,190 1,436 1,746 2,063 2, Source: Frost & Sullivan Renub Research Page 22 of 27

23 5.2 Europe, the Middle East & Africa (EMEA) Molecular Diagnostics Market The need for early diagnosis of diseases and improved therapeutic treatment is driving the adoption of molecular diagnostics tests in Europe, the Middle East & Africa (EMEA). Automated and integrated molecular diagnostic solutions have improved assay performance by decreasing the complexities involved in molecular tests. Although these solutions involve a slightly higher cost, the inherent benefits, such as reduced labor and lower cost per assay are promoting their uptake. With continued technological advances and expanding applications, molecular diagnostics is one of the fastest growing areas in the EMEA In-Vitro Diagnostics market. Overall, the uptake of molecular diagnostic tests is gaining momentum as a result of the high revenue potential in the infectious disease diagnostics market. Due to the presence of multinational companies and their dominance, the infectious disease diagnostics market is expected to offer limited opportunities to new entrants. Hence, companies would do well to be aware of the trends in the oncology diagnostics and genetic tests segments, which are currently in their growth phase and offer enormous scope for market expansion. The molecular diagnostics is poised to do better in the market, with market rose US$ 1,025 Million in 2010 and it is predicted that the market will reach US$ 1,882 Million by Renub Research Page 23 of 27

24 Figure 5-1: EMEA - Forecast for Molecular Diagnostics Market (Million US$), Million US$ 2,000 1,800 1,600 1,400 1,200 1, ,882 1,617 1,389 1, Source: Roche Analysis, Company Reports, Boston Biomedical Consultants, Renub Research Analysis Renub Research Page 24 of 27

25 Related Reports Alzheimer s Disease Patients & Market Worldwide, Future Scenario ( ) & Drugs Analysis Global Cardiovascular Surgery Devices Market Trends and Future Forecast ( ) Personalized Medicine Market ( ) - By Segments, Technologies, Opportunities, Challenges & Future Forecast World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast Glucose Monitoring Devices Market Worldwide ( ) Global Diabetes Market Trends & Future Forecast Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1 Asia Medical Tourism Analysis ( ) Global Molecular Diagnostics Market: Opportunities & Future Forecast Renub Research Page 25 of 27

26 Our Partial List of Clients Redbus Becton Dickinson Pfizer Intercell Sanofi Pasteur Stanford Burgess Pequot Capital DMI Transgene S.A. ixia communications Toyota Tsusho Amercia Inc. National Health Research Institutes Abbott Diabetes Care Corning Incorporated - Life Sciences L.E.K. Consulting GmbH Syntiron MediVas LLC Credit Suisse Dune Medical QIAGEN Inje University Mapp Biopharmaceutical Institute for Information Industry Bain WAKE Technology Services, Inc. PSS World Medical Relypsa C&K components Konkuk University Resonetics Samsung SEKISUI MEDICAL CO. LTD. Plentyoffish Media INC Arthur D Little Gmbh Morgan Stanley Takeda Pharmaceutical Corporation Hokkai School of Commerce Ministry of Manpower Singapore GenOmind, LLC. Goldman Sachs & Co NTT Advanced Technology Tokyo Womens Medical University The Chemo-Sero-Therapeutic Research Trade Council of Iceland Jpmorgan, Ets Trading GE Healthcare IT Renub Research Page 26 of 27

27 Disclaimer This research report is published by Renub Research. All rights reserved. Reproduction or redistribution of this research report in any form for any business purpose is expressly prohibited without written permission of and any payments of a specified fee. Requests to republish any material may be sent to us at info@renub.com. Most of the information available in this report is within the public domain. The submitting authors or other copyright holders retain rights for reproduction or redistribution. All persons reproducing or redistributing this information are expected to adhere to the terms and constraints invoked by the copyright holder. Such protected material, however, may be used under the terms of "fair use as defined in the copyright laws, which generally permit use for non-commercial educational purposes such as teaching, research, criticism, and news reporting. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Renub Research Page 27 of 27